1. CASE STUDY ON MYLAN'S
EPIPEN PRICING SCANDAL
Presented By
Karri Tanuja
I/II M. Pharmacy
618209507001
Drug Regulatory Affairs
1A.U. COLLEGE OF PHARMACEUTICAL
SCIENCES
3. HISTORY OF MYLAN PHARMACUETICALS
• Mylan Pharmaceuticals was found in 1961 by Milan
Puskar and Don Panoz in White Sulphur Springs, West
Virgina.
• Company first manufactured Pencillin G, along with other
generic antibiotics.
• In 2009, Mylan made it on the Fortune 500 list.
• In 2013, EpiPen Auto-Injector celebrated 25 years as the
number 1 prescribed epinephrine auto-injector.
3A.U. COLLEGE OF PHARMACEUTICAL
SCIENCES
4. WHAT IS EPIPEN
• Epinephrine, another name for the harmone Adrenaline
which is produced naturally
• It increases blood flow to the muscles during the “fight - or -
flight” responses.
• EpiPen is an Epinephrine auto-injector which is a medical
device for injecting a measured dose or doses of
epinephrine (adrenaline) by means of autoinjector
technology.
• It is most often used for the treatment of anaphylaxis.
• The first epinephrine autoinjector was brought to market in
the 1980s. 4A.U. COLLEGE OF PHARMACEUTICAL
SCIENCES
6. ABOUT THE SCANDAL
• Mylan has increased the price for a double pack of
EpiPen more than 500% in the last decade, changing the
price of the device from $100 to about $600.
For 2 packs - $103.50
By 2013 July - $264.50
By 2015 May - $461
• In a span of 1 year it again hiked its prices to $608.61.
6A.U. COLLEGE OF PHARMACEUTICAL
SCIENCES
8. MARKETING STRATEGIES OF MYLAN
While expanding the market of epipen mylan had many marketing
straegies like conducting influencing campaigns and television
advertising.
These marketing strategies had increased the sales and market share of
epipen during 2007 and 2016.
In 2015 and 2016 mylan alone exceeded a billion dollars in epipen
sales.
Finally mylan misclassifed epipen as a generic drug to escape to pay
drug rebates.
A.U. COLLEGE OF PHARMACEUTICAL
SCIENCES
8
9. CONCLUSION
Mylan agreed to pay $465 million to resolve allegations with the u.s government
that it knowingly misclassified it's branded epipen generic drug to avoid paying
rebates
Hence, right marketing strategies are to be followed by the pharmaceutical
compaines in order to avoid criticism from the tax payers.
Awarness should be created among the tax payers about the generic drugs and
the branded drugs .
A.U. COLLEGE OF PHARMACEUTICAL
SCIENCES
9
